|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
|
CN110016499B
(zh)
|
2011-04-15 |
2023-11-14 |
约翰·霍普金斯大学 |
安全测序系统
|
|
GB2513024B
(en)
|
2012-02-27 |
2016-08-31 |
Cellular Res Inc |
A clonal amplification method
|
|
PL2912468T3
(pl)
|
2012-10-29 |
2019-04-30 |
Univ Johns Hopkins |
Test papanicolaou pod kątem raka jajnika i endometrium
|
|
ES2857908T3
(es)
|
2013-08-28 |
2021-09-29 |
Becton Dickinson Co |
Análisis masivamente paralelo de células individuales
|
|
EP4180535A1
(en)
|
2015-03-30 |
2023-05-17 |
Becton, Dickinson and Company |
Methods and compositions for combinatorial barcoding
|
|
WO2017027653A1
(en)
|
2015-08-11 |
2017-02-16 |
The Johns Hopkins University |
Assaying ovarian cyst fluid
|
|
US10301677B2
(en)
|
2016-05-25 |
2019-05-28 |
Cellular Research, Inc. |
Normalization of nucleic acid libraries
|
|
US10202641B2
(en)
|
2016-05-31 |
2019-02-12 |
Cellular Research, Inc. |
Error correction in amplification of samples
|
|
KR102522023B1
(ko)
|
2016-09-26 |
2023-04-17 |
셀룰러 리서치, 인크. |
바코딩된 올리고뉴클레오티드 서열을 갖는 시약을 이용한 단백질 발현의 측정
|
|
WO2018125892A1
(en)
*
|
2016-12-28 |
2018-07-05 |
Quest Diagnostics Investments Llc |
Compositions and methods for detecting circulating tumor dna
|
|
CA3059370C
(en)
|
2017-04-12 |
2022-05-10 |
Karius, Inc. |
Methods for concurrent analysis of dna and rna in mixed samples
|
|
KR102790050B1
(ko)
|
2017-06-05 |
2025-04-04 |
백톤 디킨슨 앤드 컴퍼니 |
단일 세포를 위한 샘플 인덱싱
|
|
BR112020002555A2
(pt)
|
2017-08-07 |
2020-08-11 |
The Johns Hopkins University |
métodos e materiais para avaliar e tratar câncer
|
|
EP3775198A4
(en)
|
2018-04-02 |
2022-01-05 |
Grail, Inc. |
METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANELS
|
|
WO2019213294A1
(en)
|
2018-05-03 |
2019-11-07 |
Becton, Dickinson And Company |
High throughput multiomics sample analysis
|
|
AU2019310041B2
(en)
|
2018-07-23 |
2025-11-20 |
Guardant Health, Inc. |
Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
|
|
US12178549B2
(en)
|
2018-10-11 |
2024-12-31 |
Seno Medical Instruments, Inc. |
Optoacoustic image analysis method and system for automatically estimating lesion traits
|
|
CN113286881A
(zh)
|
2018-09-27 |
2021-08-20 |
格里尔公司 |
甲基化标记和标靶甲基化探针板
|
|
EP4471156A3
(en)
|
2018-10-01 |
2025-02-26 |
Becton, Dickinson and Company |
Determining 5' transcript sequences
|
|
JP7618548B2
(ja)
|
2018-11-08 |
2025-01-21 |
ベクトン・ディキンソン・アンド・カンパニー |
ランダムプライミングを使用した単一細胞の全トランスクリプトーム解析
|
|
WO2020123384A1
(en)
|
2018-12-13 |
2020-06-18 |
Cellular Research, Inc. |
Selective extension in single cell whole transcriptome analysis
|
|
JP2022514010A
(ja)
*
|
2018-12-20 |
2022-02-09 |
ガーダント ヘルス， インコーポレイテッド |
核酸分子の回収率を改善するための方法、組成物、およびシステム
|
|
ES2989967T3
(es)
|
2019-01-23 |
2024-11-28 |
Becton Dickinson Co |
Oligonucleótidos asociados con anticuerpos
|
|
CA3127762A1
(en)
*
|
2019-01-25 |
2020-07-30 |
Grail, Inc. |
Detecting cancer, cancer tissue of origin, and/or a cancer cell type
|
|
AU2020216438A1
(en)
*
|
2019-01-31 |
2021-07-29 |
Guardant Health, Inc. |
Compositions and methods for isolating cell-free DNA
|
|
US12071617B2
(en)
|
2019-02-14 |
2024-08-27 |
Becton, Dickinson And Company |
Hybrid targeted and whole transcriptome amplification
|
|
WO2020176659A1
(en)
|
2019-02-27 |
2020-09-03 |
Guardant Health, Inc. |
Methods and systems for determining the cellular origin of cell-free dna
|
|
JP7441243B2
(ja)
*
|
2019-05-14 |
2024-02-29 |
エフ． ホフマン－ラ ロシュ アーゲー |
試料分析のための装置および方法
|
|
EP3976822A1
(en)
|
2019-05-31 |
2022-04-06 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
CN120099137A
(zh)
|
2019-07-22 |
2025-06-06 |
贝克顿迪金森公司 |
单细胞染色质免疫沉淀测序测定
|
|
CN114269917A
(zh)
*
|
2019-08-19 |
2022-04-01 |
豪夫迈·罗氏有限公司 |
用于测序的dna和rna的单管制备
|
|
WO2021067484A1
(en)
*
|
2019-09-30 |
2021-04-08 |
Guardant Health, Inc. |
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
CN114729350A
(zh)
|
2019-11-08 |
2022-07-08 |
贝克顿迪金森公司 |
使用随机引发获得用于免疫组库测序的全长v(d)j信息
|
|
US11898199B2
(en)
|
2019-11-11 |
2024-02-13 |
Universal Diagnostics, S.A. |
Detection of colorectal cancer and/or advanced adenomas
|
|
WO2021108708A1
(en)
*
|
2019-11-26 |
2021-06-03 |
Guardant Health, Inc. |
Methods, compositions and systems for improving the binding of methylated polynucleotides
|
|
CN115151657A
(zh)
*
|
2019-12-20 |
2022-10-04 |
安可济控股有限公司 |
用于疾病检测的方法和系统
|
|
US11649497B2
(en)
|
2020-01-13 |
2023-05-16 |
Becton, Dickinson And Company |
Methods and compositions for quantitation of proteins and RNA
|
|
GB202000747D0
(en)
*
|
2020-01-17 |
2020-03-04 |
Institute Of Cancer Res |
Monitoring tumour evolution
|
|
WO2021155057A1
(en)
|
2020-01-29 |
2021-08-05 |
Becton, Dickinson And Company |
Barcoded wells for spatial mapping of single cells through sequencing
|
|
CA3170345A1
(en)
|
2020-02-14 |
2021-08-19 |
The Johns Hopkins University |
Methods and materials for assessing nucleic acids
|
|
WO2021173719A1
(en)
|
2020-02-25 |
2021-09-02 |
Becton, Dickinson And Company |
Bi-specific probes to enable the use of single-cell samples as single color compensation control
|
|
CA3167633A1
(en)
*
|
2020-02-28 |
2021-09-02 |
Pranav Parmjit SINGH |
Systems and methods for calling variants using methylation sequencing data
|
|
WO2021202752A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Guardant Health, Inc. |
Determining tumor fraction for a sample based on methyl binding domain calibration data
|
|
WO2021222828A1
(en)
|
2020-04-30 |
2021-11-04 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
WO2021231614A1
(en)
*
|
2020-05-12 |
2021-11-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
System and method for gene expression and tissue of origin inference from cell-free dna
|
|
JP2023526032A
(ja)
*
|
2020-05-13 |
2023-06-20 |
アキュラーゲン ホールディングス リミテッド |
セルフリーｄｎａサイズ検出
|
|
JP2023526252A
(ja)
|
2020-05-14 |
2023-06-21 |
ガーダント ヘルス， インコーポレイテッド |
相同組換え修復欠損の検出
|
|
EP4150118A1
(en)
|
2020-05-14 |
2023-03-22 |
Becton Dickinson and Company |
Primers for immune repertoire profiling
|
|
WO2021228418A1
(en)
|
2020-05-15 |
2021-11-18 |
Universal Diagnostics, S.L. |
Methods and systems for identifying methylation biomarkers
|
|
IL298458A
(en)
|
2020-05-22 |
2023-01-01 |
Aqtual Inc |
Methods for characterizing cell-free nucleic acid fragments
|
|
EP4158055B1
(en)
|
2020-06-02 |
2024-03-27 |
Becton, Dickinson and Company |
Oligonucleotides and beads for 5 prime gene expression assay
|
|
US11530453B2
(en)
|
2020-06-30 |
2022-12-20 |
Universal Diagnostics, S.L. |
Systems and methods for detection of multiple cancer types
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4407042A3
(en)
|
2020-07-10 |
2024-09-18 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
US11932901B2
(en)
|
2020-07-13 |
2024-03-19 |
Becton, Dickinson And Company |
Target enrichment using nucleic acid probes for scRNAseq
|
|
CN111826430A
(zh)
*
|
2020-07-24 |
2020-10-27 |
扬州大学 |
一种研究鸡PGCs中lncRNA和组蛋白甲基化酶共调控靶基因的方法
|
|
ES3018032T3
(en)
*
|
2020-07-30 |
2025-05-14 |
Guardant Health Inc |
Methods for isolating cell-free dna
|
|
WO2022026909A1
(en)
|
2020-07-31 |
2022-02-03 |
Becton, Dickinson And Company |
Single cell assay for transposase-accessible chromatin
|
|
CN116472348A
(zh)
*
|
2020-08-19 |
2023-07-21 |
安可济控股有限公司 |
用于选择性无细胞核酸分析的方法
|
|
JP2023540221A
(ja)
|
2020-08-25 |
2023-09-22 |
ガーダント ヘルス， インコーポレイテッド |
バリアントの起源を予測するための方法およびシステム
|
|
WO2022073011A1
(en)
|
2020-09-30 |
2022-04-07 |
Guardant Health, Inc. |
Methods and systems to improve the signal to noise ratio of dna methylation partitioning assays
|
|
JP2023547620A
(ja)
*
|
2020-10-23 |
2023-11-13 |
ガーダント ヘルス， インコーポレイテッド |
分配および塩基変換を使用してｄｎａを解析するための組成物および方法
|
|
WO2022103857A1
(en)
*
|
2020-11-10 |
2022-05-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single-cell profiling of chromatin occupancy and rna sequencing
|
|
EP4247969A1
(en)
|
2020-11-17 |
2023-09-27 |
Becton, Dickinson and Company |
Combined analysis of cell-free nucleic acids and single cells for oncology diagnostics
|
|
US11739443B2
(en)
|
2020-11-20 |
2023-08-29 |
Becton, Dickinson And Company |
Profiling of highly expressed and lowly expressed proteins
|
|
EP4251765A1
(en)
|
2020-11-30 |
2023-10-04 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
US12392771B2
(en)
|
2020-12-15 |
2025-08-19 |
Becton, Dickinson And Company |
Single cell secretome analysis
|
|
EP4267757A1
(en)
*
|
2020-12-23 |
2023-11-01 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
WO2022174109A1
(en)
|
2021-02-12 |
2022-08-18 |
Guardant Health, Inc. |
Methods and compositions for detecting nucleic acid variants
|
|
WO2022187867A1
(en)
*
|
2021-03-05 |
2022-09-09 |
The Trustees Of Columbia University In The City Of New York |
Methods to analyze methylomes in tumor and plasma cell-free dna
|
|
KR20230156364A
(ko)
|
2021-03-05 |
2023-11-14 |
가던트 헬쓰, 인크. |
분자 반응을 분석하기 위한 방법 및 관련 측면
|
|
US20240150825A1
(en)
*
|
2021-03-09 |
2024-05-09 |
Claret Bioscience, Llc |
Methods and compositions for analyzing nucleic acid
|
|
US20220344004A1
(en)
|
2021-03-09 |
2022-10-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on off-target polynucleotide sequencing data
|
|
WO2022204730A1
(en)
|
2021-03-25 |
2022-09-29 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
US20240191293A1
(en)
|
2021-03-30 |
2024-06-13 |
Resolution Bioscience, Inc. |
Compositions and methods for simultaneous genetic analysis of multiple libraries
|
|
US20240209455A1
(en)
*
|
2021-04-23 |
2024-06-27 |
The Translational Genomics Research Institute |
Analysis of fragment ends in dna
|
|
JP2024520422A
(ja)
|
2021-05-28 |
2024-05-24 |
ガーダント ヘルス， インコーポレイテッド |
循環分子をアッセイするための組成物および方法
|
|
WO2022271730A1
(en)
|
2021-06-21 |
2022-12-29 |
Guardant Health, Inc. |
Methods and compositions for copy-number informed tissue-of-origin analysis
|
|
US20250283170A1
(en)
*
|
2021-07-12 |
2025-09-11 |
The Trustees Of The University Of Pennsylvania |
Modified adapters for enzymatic dna deamination and methods of use thereof for epigenetic sequencing of free and immobilized dna
|
|
WO2023056065A1
(en)
|
2021-09-30 |
2023-04-06 |
Guardant Health, Inc. |
Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
|
|
JP2024540168A
(ja)
|
2021-11-02 |
2024-10-31 |
ガーダント ヘルス， インコーポレイテッド |
品質管理方法
|
|
WO2023086967A1
(en)
|
2021-11-12 |
2023-05-19 |
Guardant Health, Inc. |
Method of analysis of methylated dna-binding proteins
|
|
EP4453241A1
(en)
|
2021-12-21 |
2024-10-30 |
Guardant Health, Inc. |
Methods and systems for combinatorial chromatin-ip sequencing
|
|
EP4453240A1
(en)
|
2021-12-23 |
2024-10-30 |
Guardant Health, Inc. |
Compositions and methods for detection of metastasis
|
|
WO2023147568A2
(en)
*
|
2022-01-28 |
2023-08-03 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for making and using an immortalized library
|
|
CA3246524A1
(en)
|
2022-04-07 |
2023-10-12 |
Guardant Health, Inc. |
TUMOR PRESENCE DETECTION BASED ON THE METHYLATION STATE OF ACELLULAR NUCLEIC ACID MOLECULES
|
|
JP2025522763A
(ja)
|
2022-06-30 |
2025-07-17 |
ガーダント ヘルス， インコーポレイテッド |
異常にメチル化されたｄｎａの富化
|
|
JP2025523964A
(ja)
|
2022-07-21 |
2025-07-25 |
ガーダント ヘルス， インコーポレイテッド |
試料調製により誘発されるメチル化アーチファクトの検出および低減のための方法
|
|
WO2024040006A2
(en)
*
|
2022-08-15 |
2024-02-22 |
Bioscreening & Diagnostics Llc |
Ai and ml-based system to predict cancer from epigenetic data
|
|
JP2025532567A
(ja)
|
2022-09-16 |
2025-10-01 |
ガーダント ヘルス， インコーポレイテッド |
可溶性タンパク質を解析するための組成物および方法
|
|
EP4594522A2
(en)
|
2022-09-27 |
2025-08-06 |
Guardant Health, Inc. |
Methods for quantifying immune cell dna
|
|
JP2025538871A
(ja)
|
2022-11-15 |
2025-12-02 |
ガーダント ヘルス， インコーポレイテッド |
非小細胞肺がん（ＮＳＣＬＣ）患者の薬物応答または死亡もしくはがん進行までの時間を、循環腫瘍ＤＮＡ（ｃｔＤＮＡ）から、ベースラインｃｔＤＮＡレベルおよびｃｔＤＮＡレベルの経時的な縦断的変化の両方からのシグナルを利用して予測する方法
|
|
WO2024137682A1
(en)
|
2022-12-21 |
2024-06-27 |
Guardant Health, Inc. |
Detecting homologous recombination deficiences based on methylation status of cell-free nucleic acid molecules
|
|
EP4638781A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
EP4638782A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
WO2024151825A1
(en)
|
2023-01-11 |
2024-07-18 |
Guardant Health, Inc. |
Joint modeling of longitudinal and time-to-event data to predict patient survival
|
|
EP4655416A1
(en)
|
2023-01-25 |
2025-12-03 |
Guardant Health, Inc. |
Nucleic acid methylation profiling method
|
|
WO2024186768A1
(en)
*
|
2023-03-07 |
2024-09-12 |
Guardant Health, Inc. |
Hybrid ssdna- and dsdna-ngs library preparation methods
|
|
US20250101522A1
(en)
|
2023-04-12 |
2025-03-27 |
Guardant Health, Inc. |
Brca1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy
|
|
WO2024229143A1
(en)
|
2023-05-01 |
2024-11-07 |
Guardant Health, Inc. |
Quality control method for enzymatic conversion procedures
|
|
WO2024229433A1
(en)
|
2023-05-03 |
2024-11-07 |
Guardant Health, Inc. |
Methods for analysis of dna methylation
|
|
WO2024233502A1
(en)
|
2023-05-05 |
2024-11-14 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
WO2024259251A1
(en)
|
2023-06-15 |
2024-12-19 |
Guardant Health, Inc. |
Method for hrd detection in targeted cfdna samples using de novo mutational signatures
|
|
WO2024264065A1
(en)
|
2023-06-23 |
2024-12-26 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell nucleic acids
|
|
WO2025007034A1
(en)
|
2023-06-29 |
2025-01-02 |
Guardant Health, Inc. |
Methods for determining surveillance and therapy for diseases
|
|
WO2025007038A1
(en)
|
2023-06-30 |
2025-01-02 |
Guardant Health, Inc. |
Methods for early detection of cancer
|
|
WO2025019254A1
(en)
|
2023-07-14 |
2025-01-23 |
Guardant Health, Inc. |
Classification of breast tumors using dna methylation from liquid biopsy
|
|
WO2025019370A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Natera, Inc. |
Methods for assaying circulating tumor dna
|
|
WO2025019297A1
(en)
|
2023-07-14 |
2025-01-23 |
Guardant Health, Inc. |
Classification of colorectal tumors using dna methylation from liquid biopsy
|
|
WO2025024497A1
(en)
|
2023-07-24 |
2025-01-30 |
Guardant Health, Inc. |
Significance modeling of clonal-level target variants using methylation detection
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
US20250201344A1
(en)
|
2023-07-28 |
2025-06-19 |
Guardant Health, Inc. |
Methods and systems for identifying an origin of a variant
|
|
WO2025029751A1
(en)
|
2023-07-31 |
2025-02-06 |
Guardant Health, Inc. |
Methods and systems for identifying tumor origin
|
|
WO2025038399A1
(en)
|
2023-08-11 |
2025-02-20 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
WO2025059338A1
(en)
|
2023-09-12 |
2025-03-20 |
Guardant Health, Inc. |
Methods for analyzing nucleic acids using sequence read family size distribution
|
|
WO2025064706A1
(en)
|
2023-09-19 |
2025-03-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025064489A1
(en)
|
2023-09-20 |
2025-03-27 |
Guardant Health, Inc. |
Systems and methods for real world evidence database data integration
|
|
WO2025072084A1
(en)
*
|
2023-09-25 |
2025-04-03 |
Foundation Medicine, Inc. |
Updating records based on consensus annotations of genetic variants
|
|
WO2025072467A1
(en)
|
2023-09-29 |
2025-04-03 |
Guardant Health, Inc. |
Genotyping cyp2d6
|
|
US20250250638A1
(en)
|
2023-10-06 |
2025-08-07 |
Guardant Health, Inc. |
Genomic and methylation biomarkers for prediction of copy number loss / gene deletion
|
|
WO2025085784A1
(en)
|
2023-10-18 |
2025-04-24 |
Guardant Health, Inc. |
Genomic and methylation biomarkers for determining patient risk of heart disease and novel genomic and epigenomic drug targets to decrease risk of heart disease and/or improve patient outcome after myocardial infarction or cardiac injury
|
|
WO2025090956A1
(en)
|
2023-10-26 |
2025-05-01 |
Guardant Health, Inc. |
Methods for detecting nucleic acid variants using capture probes
|
|
WO2025090954A1
(en)
|
2023-10-26 |
2025-05-01 |
Guardant Health, Inc. |
Methods for detecting nucleic acid variants
|
|
WO2025106263A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Joint modeling of longitudinal and time-to-event data to predict patient survival
|
|
WO2025106837A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Tumor fraction and outcome association in a real-world non-small cell lung cancer (nsclc) cohort using a methylation-based circulating tumor dna (ctdna) assay
|
|
WO2025106796A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Non-small cell lung cancer (nsclc) histology classification using dna methylation data captured from liquid biopsies
|
|
WO2025106275A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Minimum residual disease (mrd) detection in early stage cancer using urine
|
|
WO2025137620A1
(en)
|
2023-12-21 |
2025-06-26 |
Guardant Health, Inc. |
Methods for high quality and high accuracy methylation sequencing
|
|
WO2025160433A1
(en)
|
2024-01-24 |
2025-07-31 |
Guardant Health, Inc. |
Methods for analyzing sequencing reads
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
US20250308636A1
(en)
|
2024-03-27 |
2025-10-02 |
Guardant Health, Inc. |
Inferring cnvs from the distribution of molecules in hyper partition
|
|
WO2025207925A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for methylation enrichment using preferential ligation of adapters
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025212664A1
(en)
|
2024-04-01 |
2025-10-09 |
Guardant Health, Inc. |
Small variant calling with error-rate based model
|
|
WO2025235602A1
(en)
|
2024-05-07 |
2025-11-13 |
Guardant Health, Inc. |
Predictive, prognostic signatures for immuno-oncology using liquid biopsy
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
US20250364077A1
(en)
|
2024-05-23 |
2025-11-27 |
Guardant Health, Inc. |
Generalized probabilistic generative modeling method for analysis of tumor methylated molecules in target capture regions
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
US12467087B1
(en)
|
2024-06-25 |
2025-11-11 |
Guardant Health, Inc. |
Sequencing methods with partitioning
|